# Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia

> **NCT01757873** · PHASE2 · COMPLETED · sponsor: **Zalicus** · enrollment: 144 (actual)

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** Z160
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01757873
- **Lead sponsor:** Zalicus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2013-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757873, "Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01757873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*